AstraZeneca, the most valuable company on the UK stock market, has hit a £200bn valuation for the first time. The pharmaceuticals giant hit the milestone today, when its shares rose by 1% – lifting its market capitalisation up from £198bn to just over £200bn this afternoon.
Trump puts tariffs on Britain.
August 24, 2025
